Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2016

View Archived Issues

Overactive bladder candidate DA-8010 may have reduced potential for dry mouth

FDA accepts IND for H3 Biomedicine's H3B-8800

siRNA-mediated knockdown of HuR suppresses tumor growth and migration in vivo

Viriom raises funding for the development of elpivirine

PABPN1 gene knockdown plus restoration partially restores muscle function in OPMD mice

rAAV8-microdystrophin improves muscular function in experimental Duchenne muscular dystrophy

TARGT platforms may be a breakthrough in the treatment of multiple CNS diseases

Merck & Co. announces ROMK channel blockers

Shanghai Fochon Pharmaceutical reports PI3Kdelta inhibitors

Roche patents disclose CYP11B2 inhibitors

GIBH and University of Texas System divulge DDR1 inhibitors

Dana-Farber Cancer Institute patents tyrosine kinase inhibitors

Ono Pharmaceutical profiles pipeline progress of fourth quarter of fiscal 2015

MolecuVax licenses a novel cancer vaccine with preclinical efficacy in breast cancer

OxStem raises funding to develop novel stem cell therapies for age-related conditions

CorMedix enters agreement with NanoProteagen to use its proprietary nanoparticle technology

Vaccitech launched from Oxford Sciences

European Commission approves Opdivo with Yervoy for advanced melanoma

Bayer terminates riociguat phase II study

Five Prime Therapeutics advances phase I/II FPA-008 study

Lundbeck recaps milestones of first quarter 2016

FDA grants orphan drug designation to Coversin for Guillain Barre syndrome

Ampio Pharmaceuticals begins Ampion phase I trial dosing

Tetraphase receives FDA guidance on eravacycline program

Adamis Pharmaceuticals enters licensing agreement

CLBS-03 designated orphan drug in U.S. to treat type 1 diabetes with residual beta cell function

Avalanche Biotechnologies completes acquisition of Annapurna Therapeutics

VolitionRx and DKFZ begin clinical testing of NuQ blood test for pancreatic cancer

European Commission approves Alprolix for hemophilia B

Grifols purchases minority state in Interstate Blood Bank

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....